BerandaABUS • NASDAQ
add
Tekmira Pharmaceuticals
$4,41
Setelah Jam Perdagangan Normal:(5,90%)-0,26
$4,15
Tutup: 17 Okt, 20.00.00 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$4,51
Rentang hari
$4,36 - $4,58
Rentang tahun
$2,71 - $5,10
Kapitalisasi pasar
845,39Â jt USD
Volume Rata-Rata
1,36Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 10,74Â jt | 522,19% |
Biaya operasional | 8,45Â jt | -61,55% |
Laba bersih | 2,52Â jt | 112,74% |
Margin laba bersih | 23,49 | 102,05% |
Penghasilan per saham | 0,01 | 109,05% |
EBITDA | 1,92Â jt | 109,15% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 98,09Â jt | -30,92% |
Total aset | 103,27Â jt | -35,48% |
Total liabilitas | 20,29Â jt | -46,02% |
Total ekuitas | 82,98 jt | — |
Saham yang beredar | 191,70 jt | — |
Harga terhadap nilai buku | 10,49 | — |
Tingkat pengembalian aset | 4,34% | — |
Tingkat pengembalian modal | 5,54% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 2,52Â jt | 112,74% |
Kas dari operasi | -15,75Â jt | -8,58% |
Kas dari investasi | 15,61Â jt | 58,83% |
Kas dari pembiayaan | 453,00Â rb | -98,14% |
Perubahan kas bersih | 336,00Â rb | -98,29% |
Arus kas bebas | -13,34Â jt | -87,90% |
Tentang
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Didirikan
2007
Kantor pusat
Situs
Karyawan
44
